University of Minnesota
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Minnesota sits in the top decile of US sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count).
University of Minnesota: 966 sponsored US clinical trials, 180 recruiting.
University of Minnesota sponsors 966 registered US clinical trials on ClinicalTrials.gov, 180 of them currently recruiting, and 671 completed. 71 of these trials are in Phase 3-4 (later-stage) and 206 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 14 trials.
Top-decile sponsor footprint
University of Minnesota ranks in the top decile of sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
671 of 731 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
966 total, page 6 of 20
FAM (Follower, Action Plan, and Remote Monitoring) Intervention to Reduce Severe Hyperglycemia in Adults With Type 1 Diabetes Mellitus at Risk for Diabetic Ketoacidosis
NCT06114186
Diaphragmatic Breathing Exercises for Post-COVID-19 Diaphragmatic Dysfunction (DD)
NCT06330376
Nasogastric/Orogastric Tube Placement Confirmation in Neonates Utilizing Self-contained pH Device, a Feasibility Study
NCT06274944
A System and Process to Improve the Satisfaction With Hearing Health Products
NCT04926636
Treatment of LSCD With DM
NCT05909735
Feasibility, Acceptability, and Preliminary Efficacy of a Six-week Physical Activity Intervention for Black Women
NCT05997888
Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia
NCT06111027
Semaglutide in CFRD
NCT05788965
Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant Recipients
NCT05663463
Physical Activity Variety's Impact on Physical Activity Participation
NCT05930431
duoABLE for People With Stroke and Their Caregivers
NCT05964400
Partners for Pain & Wellbeing Equity: A Randomized Trial of Community Supported Complementary and Integrative Health Self-management for Back Pain
NCT05786508
State Dependence of Prefrontal Transcranial Magnetic Stimulation
NCT05962385
Sex Differences in the effecTs of brEaking uP Sedentary Behavior on vascUlar Function in Type 2 Diabetes
NCT05838586
Non-Invasive Cardiac Output Monitor (NICOM) for Goal-directed Fluid Resuscitation for Inpatients With Hypotension and/or Septic Shock
NCT05630716
Affective Social Buffering
NCT04312945
Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial
NCT05822583
Remotely Delivered Cognitive Multisensory Rehabilitation for Sensory and Motor Recovery After Spinal Cord Injury
NCT05870189
Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted Communities
NCT05651581
Dietary Optimization of Microbiome Recovery Following Fecal Microbiota Transplantation
NCT05826418
Combining tDCS and CILT in Non-fluent Aphasia
NCT05561400
Home Alone: An Intervention for People With Cognitive Impairment Who Live Alone
NCT05746390
Treatment Burden Screening Questionnaire Pilot Study
NCT05870202
HPV Self-Sampling in Somali Women (Isbaar Project)
NCT05453006
A Feasibility Study of Topical Cannabinoids for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in Adults With Hormone Receptor-Positive Breast Cancer (CanAroma)
NCT05935891
Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias
NCT06357169
Mobile Food Market Cluster Randomized Trial
NCT05672186
Bacterial Intestinal Gut Modification Around Cancer Surgery (BIG MACS) Diet
NCT05658263
The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial
NCT05650645
Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
NCT05639946
Preliminary Efficacy of a Strength Training Intervention on Exercise Adherence and Weight Among Pre-Menopausal Women
NCT05426070
Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)
NCT05605093
Testing A Visual Thermometer in Newborns and Young Infants
NCT05609292
Theta Phase-specific TMS to Modulate Prefrontal Activity
NCT05416138
CGM Use in Preterm Infants
NCT05436925
Assessment of Bimodal Stimulation Device Compliance and Satisfaction in Individuals With Tinnitus
NCT05518682
A Mobile Informatics Solution to Aid in Memory
NCT04700540
Capillary Refill Time Measurement Utilizing Mobile Application in Children
NCT05472116
State Representation in Early Psychosis - Project 4
NCT05664594
Remote State Representation in Early Psychosis
NCT05538832
Mechanisms of a Dynamic Stability Approach
NCT05247398
Traumatic Brain Injury and Alzheimer's Disease/Related Dementias Caregiver Support Intervention
NCT05465109
Novel DBS Device in Parkinson's Disease
NCT07213999
BUMPP: A Study to Better Understand Mood During the Perinatal Period
NCT05537259
Telerehabilitation for TMD
NCT05318313
BCT-HA Kit for Dehydrated and Wrinkled Skin
NCT05514834
Measuring and Enhancing Creativity and Brain Flexibility in Adolescents With Depression
NCT07605975
A Clinical Trial of Cognitive Multisensory Rehabilitation for Sensory and Motor Recovery in Adults With Spinal Cord Injury
NCT05167032
Teen Brain Training (TBT)
NCT06183580
Cleansing Device for the Treatment of Scalp and Hair Conditions
NCT05319444
What is open in the University of Minnesota pipeline
180 recruiting of 966 indexed (19% open); 671 completed (69%).
Phase mix: 71 late (III/IV) vs 206 early (I/II) (early-phase heavy).
Top condition: Obesity (14 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Minnesota: open-pipeline peers nationwide
Peers matched on 966 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 966 trials (± recruiting share)
- Columbia University · 958 trials · 18% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Alabama at Birmingham · 19% recruiting · 1,160 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Minnesota page
966 registered trials is a research-attention snapshot, not an endorsement of University of Minnesota or any single study.
- 180 of University of Minnesota's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Minnesota studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Minnesota pipeline card: 966 registered trials from official public datasets.Report a data error.